http://purl.org/np/RAUwXf4o2NgsSvgR47U8CwxXV_IKfYna0t0PuyXK-8Jh4#Head
http://purl.org/np/RAUwXf4o2NgsSvgR47U8CwxXV_IKfYna0t0PuyXK-8Jh4
http://www.nanopub.org/nschema#hasAssertion
http://purl.org/np/RAUwXf4o2NgsSvgR47U8CwxXV_IKfYna0t0PuyXK-8Jh4#assertion
http://purl.org/np/RAUwXf4o2NgsSvgR47U8CwxXV_IKfYna0t0PuyXK-8Jh4
http://www.nanopub.org/nschema#hasProvenance
http://purl.org/np/RAUwXf4o2NgsSvgR47U8CwxXV_IKfYna0t0PuyXK-8Jh4#provenance
http://purl.org/np/RAUwXf4o2NgsSvgR47U8CwxXV_IKfYna0t0PuyXK-8Jh4
http://www.nanopub.org/nschema#hasPublicationInfo
http://purl.org/np/RAUwXf4o2NgsSvgR47U8CwxXV_IKfYna0t0PuyXK-8Jh4#pubInfo
http://purl.org/np/RAUwXf4o2NgsSvgR47U8CwxXV_IKfYna0t0PuyXK-8Jh4
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://purl.org/np/RAUwXf4o2NgsSvgR47U8CwxXV_IKfYna0t0PuyXK-8Jh4#assertion
http://purl.org/np/RAUwXf4o2NgsSvgR47U8CwxXV_IKfYna0t0PuyXK-8Jh4#assertion
http://www.w3.org/ns/prov#wasGeneratedBy
S&T TWOC project version 1
http://purl.org/np/RAUwXf4o2NgsSvgR47U8CwxXV_IKfYna0t0PuyXK-8Jh4#version
http://www.w3.org/ns/prov#value
1
http://www.w3.org/1999/02/22-rdf-syntax-ns#object
https://uts.nlm.nih.gov/uts/umls/concept/C1947944
use
http://www.w3.org/1999/02/22-rdf-syntax-ns#object
https://uts.nlm.nih.gov/uts/umls/concept/C5383282
convalescent plasma therapy
http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate
http://twoc-nlp-database-server-1:8555/solr/predicates/select?q=TRIPLE_UID:fv8lr3bm-TRIPLE-ABSTRACT-11
call
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://uts.nlm.nih.gov/uts/umls/concept/C0003241
antibody
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://uts.nlm.nih.gov/uts/umls/concept/C0005841
transfusion
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://uts.nlm.nih.gov/uts/umls/concept/C0011777
dexamethasone
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://uts.nlm.nih.gov/uts/umls/concept/C0021027
antibody
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://uts.nlm.nih.gov/uts/umls/concept/C1167408
antibody
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://uts.nlm.nih.gov/uts/umls/concept/C1621287
antibody
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://uts.nlm.nih.gov/uts/umls/concept/C1879316
transfusion
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://uts.nlm.nih.gov/uts/umls/concept/C3665580
antibody
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://uts.nlm.nih.gov/uts/umls/concept/C5203670
COVID-19
http://www.w3.org/2000/01/rdf-schema#Triple-UID
http://twoc-nlp-database-server-1:8555/solr/triples/select?q=TRIPLE_UID:fv8lr3bm-TRIPLE-ABSTRACT-11
fv8lr3bm-TRIPLE-ABSTRACT-11
http://www.w3.org/2000/01/rdf-schema#sentence
http://www.w3.org/2000/01/rdf-schema#label
Severe acute respiratory distress coronavirus 2 (SARS)-CoV-2) virus is responsible for the current pandemic - coronavirus disease 2019 (COVID)-19) plaguing the world Severe acute respiratory distress coronavirus 2 (SARS)-CoV-2) virus began spreading as early as January 2020 in the United States (US) and has recently become the leading cause of death amongst adults over 45 years of age Much of Severe acute respiratory distress coronavirus 2 (SARS)-CoV-2) virus's clinical presentation is already known, and there have been advances in Severe acute respiratory distress coronavirus 2 (SARS)-CoV-2) virus's successful treatment with a food and drug administration (FDA) approved antiviral medication called remdesivir, and other proven investigational methods with clinical benefits including dexamethasone and Severe acute respiratory distress coronavirus 2 (SARS)-CoV-2) virus antibody transfusion called convalescent plasma therapy However, the recommendations for other proven investigational methods with clinical benefits including dexamethasone and COVID-19 antibody transfusion called convalescent plasma therapy's use include COVID-19 confirmed patients requiring supplemental oxygen or other forms of respiratory support In this case report, we describe in detail a unique case of severe Severe acute respiratory distress coronavirus 2 (SARS)-CoV-2) virus infection that did not require any form of oxygen support hut was treated successfully with antiviral medications and steroids The purpose of this case report is to highlight in detail an unusual Severe acute respiratory distress coronavirus 2 (SARS)-CoV-2) virus presentation with rhabdomyolysis, myocarditis, and pancytopenia severe enough to require hospitalization and treatment with proven Severe acute respiratory distress coronavirus 2 (SARS)-CoV-2) virus therapy to achieve clinical resolution
http://www.w3.org/2000/01/rdf-schema#triple
http://www.w3.org/2000/01/rdf-schema#label
dexamethasone and COVID-19 antibody transfusion called convalescent plasma therapy s use
http://purl.org/np/RAUwXf4o2NgsSvgR47U8CwxXV_IKfYna0t0PuyXK-8Jh4#provenance
http://purl.org/np/RAUwXf4o2NgsSvgR47U8CwxXV_IKfYna0t0PuyXK-8Jh4#assertion
http://www.w3.org/ns/prov#generatedAtTime
2021-07-25T21:47:44.864391
http://purl.org/np/RAUwXf4o2NgsSvgR47U8CwxXV_IKfYna0t0PuyXK-8Jh4#pubInfo
http://purl.org/np/RAUwXf4o2NgsSvgR47U8CwxXV_IKfYna0t0PuyXK-8Jh4#sig
http://purl.org/nanopub/x/hasAlgorithm
RSA
http://purl.org/np/RAUwXf4o2NgsSvgR47U8CwxXV_IKfYna0t0PuyXK-8Jh4#sig
http://purl.org/nanopub/x/hasPublicKey
MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCSLeezU8JYlBsrgXOGXX4fxOq4oydsMzMK1CN0Rez2OEd2IYk18R4DetcZXwGhN3Pil7qcgNkiGvTirJXIo8zHl7jVehs19EdYtrttCKEaXRzWIr4LuCrfGedkvonEMWqR8e1GdQsLgEEyM50BD6Qw+srQt9ozcqf/9wG2MAMX9QIDAQAB
http://purl.org/np/RAUwXf4o2NgsSvgR47U8CwxXV_IKfYna0t0PuyXK-8Jh4#sig
http://purl.org/nanopub/x/hasSignature
GlZA70ScsPN63HJ5hL65ON/Gg1tCXHstoPc37eO3NjZswFlYu6CIOp6XzBctxIBqDEHskPkp6Lvx5ljJ8M8jcUJxhJAHVGDamm8Hz9cCo6KdsEWcKsHz2eH0pOXqrtc0sNMjGbHTe8B58WzctRMVIk0fTMd4ro35ZIQaZeqyeUA=
http://purl.org/np/RAUwXf4o2NgsSvgR47U8CwxXV_IKfYna0t0PuyXK-8Jh4#sig
http://purl.org/nanopub/x/hasSignatureTarget
http://purl.org/np/RAUwXf4o2NgsSvgR47U8CwxXV_IKfYna0t0PuyXK-8Jh4
http://purl.org/np/RAUwXf4o2NgsSvgR47U8CwxXV_IKfYna0t0PuyXK-8Jh4
http://www.w3.org/ns/prov#generatedAtTime
2021-07-25T21:47:44.864391
http://purl.org/np/RAUwXf4o2NgsSvgR47U8CwxXV_IKfYna0t0PuyXK-8Jh4
http://www.w3.org/ns/prov#wasAttributedTo
https://orcid.org/0000-0002-8954-0470